Rocket Pharmaceuticals (RCKT)
(Delayed Data from NSDQ)
$22.82 USD
-0.22 (-0.95%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $22.82 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.74 | 0.38% |
Earnings Summary
For their last quarter, Rocket Pharmaceuticals (RCKT) reported earnings of -$0.66 per share, beating the Zacks Consensus Estimate of $-0.69 per share. This reflects a positive earnings surprise of 4.35%. Look out for RCKT's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.74 per share, reflecting a year-over-year increase of 9.76%.
Earnings History
Price & Consensus
Zacks News for RCKT
FDA Rejects Rocket's (RCKT) Gene Therapy BLA for Rare Disease
RCKT: What are Zacks experts saying now?
Zacks Private Portfolio Services